Építés alatt – nem éles oldal

Ugrás a tartalomra

Frontlight Research

Intézmény

Joslin Diabetes Center

Boston, Egyesült ÁllamokHonlap

33futó vizsgálat
27lezárt vizsgálat
0a helyszín által az elmúlt 60 napban megerősített vizsgálat
–nyelv nincs megadva

A helyszín még egy vizsgálatot sem erősített meg.

Futó vizsgálatok

Még nem toboroz
Platform Trial in Stage 1 Diabetes: Comparing Golimumab vs Placebo
NCT07683026· 2. fázis· Forrás
Toboroz
App-Based Certified Diabetes Education Therapy (AB-CDE)
NCT07282639· Forrás
Toboroz
Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus
NCT07142252· 2. fázis· Forrás
Toboroz
Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System
NCT07579702· Forrás
Toboroz
Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes
NCT07521475· Forrás
Toboroz
INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes
NCT07224321· 2. fázis· Forrás
Toboroz
Nutrition+: Effect of a High-Protein Diabetes Formula on Body Composition in Type 2 Diabetes Patients Treated With Incretin Mimetics
NCT07271043· Forrás
Toboroz
Postnatal Exercise to Activate Baby's Brown Fat
NCT07467694· Forrás
Toboroz
Exercise, Brain Activity, and Weight Maintenance
NCT06511310· Forrás
Toboroz
A Study of GNTI-122 in Adults Recently Diagnosed With T1D
NCT06919354· 1. fázis· Forrás
Toboroz
Faricimab + PRP vs. Vitrectomy + Endolaser for Treatment of PDR
NCT06790784· 3. fázis· Forrás
Toboroz
HLA Demographics Study in Adults With Type 1 Diabetes
NCT06860516· Forrás
Toboroz
CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)
NCT06783309· 1/2. fázis· Forrás
Fut, nem toboroz
T1D Pregnancy & Me
NCT06959316· Forrás
Toboroz
Diabetes Body Project 2
NCT07468188· Forrás
Toboroz
Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
NCT06217302· 3. fázis· Forrás
Fut, nem toboroz
Frexalimab in Preservation of Endogenous Insulin Secretion Compared to Placebo in Adults and Adolescents on Top of Insulin Therapy (FABULINUS)
NCT06111586· 2. fázis· Forrás
Fut, nem toboroz
Home OCT-Guided Treatment Versus Treat and Extend for the Management of Neovascular AMD
NCT05904028· 3. fázis· Forrás
Fut, nem toboroz
Rituximab-pvvr and Abatacept vs Rituximab-pvvr Alone in New Onset Type 1 Diabetes
NCT03929601· 2. fázis· Forrás
Fut, nem toboroz
Janus Kinase (JAK) Inhibitors to Preserve C-Peptide Production in New Onset Type 1 Diabetes (T1D)
NCT05743244· 2. fázis· Forrás
Fut, nem toboroz
Evaluation of Tonabersat for DME
NCT05727891· 2. fázis· Forrás
Fut, nem toboroz
The PRECISION II Study: Evaluating the Accuracy of the LabPatch Glucose Sensing System
NCT05754281· Forrás
Fut, nem toboroz
Multi-Site Eating Disorder Prevention Program for Type 1 Diabetes
NCT05399446· Forrás
Toboroz
PRenatal and Obstetric Maternal Exposures and ISlet Autoantibodies in Early Life
NCT06141434· Forrás
Meghívásos bevonás
The Diabetes Prevention Program Outcomes Study AD/ADRD Project
NCT05704309· Forrás
Fut, nem toboroz
Fenofibrate for Prevention of DR Worsening
NCT04661358· 3. fázis· Forrás
Fut, nem toboroz
Prevalence of NAFLD and Advanced Fibrosis in Patients With Type 1 Diabetes
NCT04595474· Forrás
Toboroz
Kidney Precision Medicine Project
NCT04334707· Forrás
Fut, nem toboroz
A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 Diabetes
NCT03811561· 3. fázis· Forrás
Fut, nem toboroz
Impact of Metabolic Health on Sperm Epigenetic Marks in Humans
NCT03860558· Forrás
Toboroz
Type 1 Diabetes Extension Study
NCT02734277· Forrás
Fut, nem toboroz
Evaluating the Health Outcomes of the Joslin Why WAIT Program
NCT01937845· Forrás
Toboroz
TrialNet Pathway to Prevention of T1D
NCT00097292· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

Kutatók

Ide még nem kötődik kutató.

Lezárt vizsgálatok

Lezárult
Simplified Onboarding in Adults With Type 2 Diabetes
NCT07070830· Forrás
Visszavonták
SYNERGY PLUS: Evaluation of Next Generation Sensors (NGS) and Algorithm in Patients With Type 1 and Type 2 Diabetes
NCT06719531· Forrás
Lezárult
Innovative Automated Insulin Delivery System for Type 2 Diabetes
NCT06853990· Forrás
Lezárult
Omnipod® SmartAdjust 2.0 System Compared to the Omnipod® 5 System in Individuals With Type 1 or Type 2 Diabetes
NCT06865989· Forrás
Lezárult
A Study to Evaluate Pharmacokinetics of LY3209590 in Pediatric Participants With Type 2 Diabetes Mellitus
NCT06362265· 1. fázis· Forrás
Lezárult
A Study to Learn How Well the Study Treatment Finerenone Works and How Safe it is in People With Long-term Decrease in the Kidneys' Ability to Work Properly (Chronic Kidney Disease) Together With Type 1 Diabetes
NCT05901831· 3. fázis· Forrás
Lezárult
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor
NCT06221969· 3. fázis· Forrás
Lezárult
A Study of Orforglipron (LY3502970) Compared With Semaglutide in Participants With Type 2 Diabetes Inadequately Controlled With Metformin
NCT06045221· 3. fázis· Forrás
Lezárult
INHALE-3: Afrezza® Combined With Insulin Degludec Versus Usual Care in Adults With Type 1 Diabetes
NCT05904743· 4. fázis· Forrás
Lezárult
Safety and Effectiveness of the MiniMed™ 780G System With DS5 CGM
NCT05714059· Forrás
Lezárult
Use of Control-IQ Technology 2.0 in Adults, Children, and Preschoolers With Type 1 Diabetes
NCT05683392· Forrás
Lezárult
Deprescribing of Diabetes Regimens in Long Term Care Residents With Alzheimer's
NCT05535478· Forrás
Lezárult
A Research Study to Look Into How Semaglutide, Together With a Lower Dose of Insulin Glargine, Compares to a Higher Dose of Insulin Glargine Alone in People With Type 2 Diabetes (SUSTAIN OPTIMIZE)
NCT05514535· 3. fázis· Forrás
Lezárult
Healthy And Positive Pathways for Young People With Type 1 Diabetes (HAPPY T1D)
NCT05413239· Forrás
Lezárult
Omnipod 5 System Compared to Pump Therapy
NCT05409131· Forrás
Lezárult
A Pilot Study of Fenofibrate to Prevent Kidney Function Loss in Type 1 Diabetes
NCT04929379· 2. fázis· Forrás
Lezárult
Afrezza® INHALE-1 Study in Pediatrics
NCT04974528· 3. fázis· Forrás
Lezárult
Oral Hypoglycemic Therapy for Monogenic Variant Carriers of the Joslin Medalist Study
NCT04409795· 2/3. fázis· Forrás
Lezárult
Effects of a Single Bout of Exercise on Transcriptomics and Metabolomics in Adipose Tissue
NCT04865965· Forrás
Leállították
IMCY-0098 Proof of ACtion in Type 1 Diabetes (IMPACT Study)
NCT04524949· 2. fázis· Forrás
Lezárult
A Multiple Ascending Dose Trial Investigating Safety, Tolerability and Pharmacokinetics of NNC0361-0041
NCT04279613· 1. fázis· Forrás
Lezárult
A Study to Evaluate THR-149 Treatment for Diabetic Macular Oedema
NCT04527107· 2. fázis· Forrás
Lezárult
A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes
NCT04255433· 3. fázis· Forrás
Lezárult
Safety, Tolerability and Potential Efficacy of AVT001 in Patients With Type 1 Diabetes
NCT03895996· 1/2. fázis· Forrás
Lezárult
Alliance of Randomized Trials of Medicine vs Metabolic Surgery in Type 2 Diabetes
NCT02328599· Forrás
Lezárult
Exercise Regulation of Human Adipose Tissue
NCT03133156· Forrás
Lezárult
Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans
NCT01762046· 1. fázis· Forrás

Vizsgálati helyszínek

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

Intézményadatok: ROR 0280a3n32 (CC0-1.0)Frissítve: 2026. nov. 10.

Építés alatt, nem éles – Joslin Diabetes Center: vizsgálatok és kutatócsoportok – Frontlight Research